HELX
Franklin Genomic Advancements ET
HELX
29,22
0,01 Bil. AUM
0,5% Expense Ratio
32,11 NAV
Franklin Genomic Advancements ET Profile
About Franklin Genomic Advancements ET
Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.
- Company
- Holdings
- 63
- CUSIP
- 35473P520
Franklin Genomic Advancements ET Sectors
| Industry | Percentage |
|---|---|
| Healthcare | 95,27% |
| Basic Materials | 2,60% |
| Technology | 1,84% |
| Real Estate | 0,29% |
| Industrials | 0,00% |
| Financial Servic | 0,00% |
| Energy | 0,00% |
| Consumer Defensi | 0,00% |
| Consumer Cyclica | 0,00% |
| Communication Se | 0,00% |
| Utilities | 0,00% |